Corcept Therapeutics Incorporated financial statements, including revenue, expenses, profit, and loss

The total revenue of CORT for the last quarter is 146.81 M USD, and it's 8.42% higher compared to the previous quarter. The net income of Q1 24 is 27.51 M USD.